At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Peripheral Intravenous Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Controlled Post-market Study to Assess the Impact of Peripheral Intravenous Catheter Length and Gauge on Catheter Indwell Duration and Haemolysis in Human Participants Using a Bilateral, Cephalic Vein Cannulation Model
In Brief
A clinical study evaluating Peripheral Intravenous Catheter for Indication for Peripheral Intravenous Catheterisation. Completed, enrolled 40 participants across 1 site.
Detailed Summary
This is a single-centre, open-label, multi-visit study design, in 40 healthy participants, randomized by gauge of peripheral intravenous catheter (PIVC) device into the lower arm cephalic vein of both arms. The purpose of this study is to assess impact of catheter length and gauge on PIVC indwell time over a 72 hour period. This study will also evaluate the incidence of haemolysis using blood draws from the PIVC.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustralia
CollaboratorsGriffith University
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedApr 2020
Enrollment StartAug 2020
Primary CompletionMar 2021
TodayJul 2026
First PostedApr 14, 2020
Enrollment StartAug 31, 2020
Primary CompletionMar 12, 2021
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 6.2 years ago
Interventions
Peripheral Intravenous Catheterdevice
Randomised controlled